@TechReport{iza:izadps:dp18787,
            	author={Daysal, N. Meltem and Fredrickson, Camille and Kristiansen, Ida Lykke and Trandafir, Mircea and Zhang, Jonathan},
            	title={The Labor Market Impacts of GLP-1s},
            	year={2026},
	month={Jul},
            	institution={Institute of Labor Economics (IZA)},
            	address={Bonn},
            	type={IZA Discussion Paper},
            	number={18787},
            	url={https://www.iza.org/publications/dp18787},
	abstract={We estimate the causal impacts of GLP-1 treatment on labor market outcomes using linked Danish administrative data and a matched stacked difference-in-differences design. We compare patients who initiate GLP-1 treatment during the first two years of Semaglutide availability to observably similar patients who initiate four years later. We find that GLP-1 treatment reduces long-term sickness leave by 17.3%. We estimate total fiscal benefits of GLP-1 initiation of approximately 1.3–1.5% of annual labor income per employed individual. We do not detect statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.},
	keywords={GLP-1;diabetes;obesity;fiscal spillover},
            }